Ha Y, Lee J E, Kim K N, Cho Y E, Yoon D H
Department of Neurosurgery, Yonsei University College of Medicine, Seoul, Korea.
Acta Neurochir (Wien). 2003 Jun;145(6):483-7. doi: 10.1007/s00701-003-0023-4.
Nestin is an intermediate protein and a well-known specific neural stem cell antigen. Some bone marrow stem cells can generate not only blood cells but also neurons and glial cells under specific culture conditions. Furthermore, in vitro cultured bone marrow stem cells also express nestin antigen. However, it is unclear whether cord blood cells also differentiate into neural cells or not. In this study, we investigated the expression of nestin on human cord blood monocytes (HCMNCs) and we discuss the relevance of this finding upon future therapeutic applications of HCMNCs in neurological diseases.
HCMNCs were prepared from normal placenta after full-term normal delivery. Immunocytochemical staining and reverse transcriptase polymerase chain reaction (RT-PCR) for nestin and CD133 antigen were performed to confirm nestin and CD133 antigen expression in the HCMNCs.
Some nestin expressing HCMNCs were found. Immunocytochemical staining showed that some of the blood stem cell marker CD133 expressing cells co-expressed nestin. RT-PCR demonstrated nestin and CD133 mRNA in HCMNCs, but not in adult blood monocytes. Approximately, 60 +/- 8% of CD133 expressing cells expressed nestin.
In the present study, we found that more than 60% of CD133 expressing HCMNCs also express nestin antigen in their cytoplasm, which supports the idea that cord blood stem cells can adopt a neuronal fate.
巢蛋白是一种中间丝蛋白,是一种著名的神经干细胞特异性抗原。一些骨髓干细胞在特定培养条件下不仅能生成血细胞,还能生成神经元和神经胶质细胞。此外,体外培养的骨髓干细胞也表达巢蛋白抗原。然而,脐血细胞是否也能分化为神经细胞尚不清楚。在本研究中,我们调查了巢蛋白在人脐血单核细胞(HCMNCs)上的表达情况,并讨论了这一发现与HCMNCs未来在神经疾病治疗应用中的相关性。
从足月正常分娩后的正常胎盘中制备HCMNCs。进行巢蛋白和CD133抗原的免疫细胞化学染色及逆转录聚合酶链反应(RT-PCR),以确认HCMNCs中巢蛋白和CD133抗原的表达。
发现了一些表达巢蛋白的HCMNCs。免疫细胞化学染色显示,一些表达造血干细胞标志物CD133的细胞同时表达巢蛋白。RT-PCR证实HCMNCs中有巢蛋白和CD133 mRNA,但成人血单核细胞中没有。大约60±8%表达CD133的细胞表达巢蛋白。
在本研究中,我们发现超过60%表达CD133的HCMNCs在其细胞质中也表达巢蛋白抗原,这支持了脐血干细胞可向神经元命运转变的观点。